Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A stable, multi-subunit complex of beta2glycoprotein I

M Galazka1, L B Keil, J D Kohles

  • 1Department of Chemistry, College of Arts and Sciences, School of Graduate Medical Education, Seton Hall University, South Orange, New Jersey, USA.

Thrombosis Research
|July 31, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monthly ibandronate suppresses serum CTX-I within 3 days and maintains a monthly fluctuating pattern of suppression.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2009
Same author

Rapid suppression of bone resorption marker levels with ibandronate therapy in a bisphosphonate-naïve population.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry·2008
Same author

Inhibition of beta 2glycoprotein I binding to anionic phospholipids: a strategy for the development of antiphospholipid syndrome-specific drugs.

Drug design and discovery·2000
Same author

The hololipoprotein complex of beta(2)-glycoprotein I and dicaproyl phosphatidylserine.

International journal of clinical & laboratory research·1999
Same author

Modification of beta 2glycoprotein I by glutardialdehyde. Conformational changes and aggregation accompany exposure of the cryptic autoepitope.

Applied biochemistry and biotechnology·1999
Same author

The ribosomal DNA loci in Plasmodium falciparum accumulate mutations independently.

Journal of molecular biology·1995

Beta2glycoprotein I (beta2GPI) forms a multimeric complex with an 8-kDa protein, challenging its traditional view as a single 54-kDa molecule. This finding impacts understanding of antiphospholipid syndrome autoantigen structure.

Area of Science:

  • Biochemistry
  • Immunology
  • Structural Biology

Background:

  • Beta2glycoprotein I (beta2GPI) is a key autoantigen in antiphospholipid syndrome (APS).
  • Previous understanding identified beta2GPI as a 54-kDa plasma protein.

Purpose of the Study:

  • To investigate the native structure and composition of beta2GPI.
  • To elucidate the molecular assembly of beta2GPI in its functional state.

Main Methods:

  • Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under reducing conditions.
  • Native polyacrylamide gel electrophoresis (Native PAGE) without detergent or reducing agents.
  • Atomic force microscopy (AFM) to visualize native beta2GPI structure.

Main Results:

Related Experiment Videos

  • SDS-PAGE revealed a 54-kDa beta2GPI band alongside an 8-kDa protein band.
  • Native PAGE showed beta2GPI exists as a large, approximately 320 kDa complex, dissociable into smaller units including the 8-kDa protein.
  • AFM imaging demonstrated native beta2GPI as aggregates of 30-35 nm particles, larger than expected for a 54-kDa monomer.

Conclusions:

  • Beta2glycoprotein I (beta2GPI) exists as a multimeric complex, not solely as a 54-kDa monomer.
  • The 8-kDa protein is an integral component of the native beta2GPI complex.
  • These findings suggest a revised structural model for beta2GPI relevant to APS pathogenesis.